Catalyst Wire Dossier Catalyst Wire Dossier

OPIPZA

ARIPIPRAZOLE · Carwin Pharmaceutical Associates, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OPIPZA, covering 2024-07-22 to 2025-03-20. Get the full timeline:

Most recent: FDA Approved: OPIPZA — Supplemental Application (Carwin Pharmaceutical Associates, LLC)

See pricing